News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Girolamo Todd C
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/13/2022 |
4
| Girolamo Todd C (Chief Legal Officer) has filed a Form 4 on PROKIDNEY CORP.
Txns:
| Granted 327,713 options to buy
@ $0 |
|
07/13/2022 |
3
| Girolamo Todd C (Chief Legal Officer) has filed a Form 3 on PROKIDNEY CORP. |
02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/22/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/18/2022 |
4
| Girolamo Todd C (CLO, SVP of Corp Dev) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns:
| Paid exercise price by delivering 2,563 shares
@ $0.8063, valued at
$2.1k
Paid exercise price by delivering 2,158 shares
@ $0.8204, valued at
$1.8k
|
|
01/12/2022 |
4
| Girolamo Todd C (CLO, SVP of Corp Dev) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.
Txns:
| Granted 129,000 shares
@ $0 Paid exercise price by delivering 17,405 shares
@ $0.917, valued at
$16k
Paid exercise price by delivering 4,722 shares
@ $0.8651, valued at
$4.1k
Granted 65,000 options to buy
@ $0.917, valued at
$59.6k
|
|
11/08/2021 |
3
| Girolamo Todd C (CLO, SVP of Corp Dev) has filed a Form 3 on CALADRIUS BIOSCIENCES, INC. |
|
|